HEPATITIS C AND HEDGE FUND PROFITEERS Meet The Hedge Fund Managers Cashing In On Predatory Drug Pricing Schemes from Gilead Sciences For millions of Americans infected with Hepatitis C, the … Continue reading #HedgePapers No. 13 – Hepatitis C and Hedge Fund Profiteers